Chapter 61 Incontinence Q&A (1 of 18) Sample Questions
1. A 55-year-old female has stress incontinence. She has 3 children. Best option to manage this type of incontinence is:
- A. Systemic estrogen
- B. Imipramine
- C. Pelvic floor muscle training (PFMT)
- D. Vaginal estrogen
Ans:
C
Tips: This type of urinary incontinence is not usually treated pharmacologically. First-line treatment focuses on pelvic floor muscle training.
Estrogen therapy is ineffective and should not be used to manage this type of urinary incontinence. Although duloxetine reduces the frequency of urinary incontinence episodes and improves quality of life compared with placebo, it is associated with increased adverse effects (e.g., nausea, diarrhea, headache, dizziness, fatigue, dry mouth, liver toxicity, suicidal ideation).Duloxetine is not licensed in Canada for the management of stress urinary incontinence.
Estrogen therapy is ineffective and should not be used to manage this type of urinary incontinence. Although duloxetine reduces the frequency of urinary incontinence episodes and improves quality of life compared with placebo, it is associated with increased adverse effects (e.g., nausea, diarrhea, headache, dizziness, fatigue, dry mouth, liver toxicity, suicidal ideation).Duloxetine is not licensed in Canada for the management of stress urinary incontinence.